INSM – insmed incorporated (US:NASDAQ)
Stock Stats
News
4/2
03:02 am
insm
Low
Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts [Yahoo! Finance]
3/25
08:27 am
insm
Low
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference [Yahoo! Finance]
3/25
08:00 am
insm
Low
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
3/20
10:43 am
insm
Low
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Bank of America Co. from $92.00 to $96.00. They now have a "buy" rating on the stock.
3/19
10:45 am
insm
Low
Insmed Incorporated (NASDAQ: INSM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
2/20/2025
07:00 am
insm
-1.6%
MISS
2/20/2025
07:00 am
insm
2.0%
MISS
2/20/2025
07:00 am
insm
3.7%
MISS
2/20/2025
07:00 am
insm
3.6%
MISS
3/19
10:45 am
Reiterates
Outperform
Outperform
Royal Bank of Canada
Low
1.6%
3/19
10:45 am
Reiterates
Outperform
Outperform
Royal Bank of Canada
Low
1.6%
3/19
10:36 am
Reiterates
Outperform
Outperform
RBC Capital
Low
1.5%
3/19
10:36 am
Reiterates
Outperform
Outperform
RBC Capital
Low
1.5%
3/6
06:22 pm
Maintains
Buy
Buy
UBS
Low
-0.2%
4/4
08:18 am
insm
Medium
Form ARS INSMED Inc For: Dec 31
4/4
08:17 am
insm
Medium
Form DEFA14A INSMED Inc
4/4
08:16 am
insm
Medium
Form DEF 14A INSMED Inc For: May 15
4/3
04:25 pm
insm
Medium
Form 4 INSMED Inc For: Apr 01 Filed by: Lewis William
4/1
04:48 pm
insm
Low
Form 144 INSMED Inc Filed by: Lewis William
Show more
Top News Gainers
2/3 Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis 40.6%
2/4 Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Goldman Sachs Group Inc from $33.00 to $46.00. They now have a "buy" rating on the stock. 12.6%
3/17 Insmed Incorporated (NASDAQ: INSM) had its price target lowered by analysts at Stifel Nicolaus from $55.00 to $45.00. They now have a "buy" rating on the stock. 12.6%
4/30 Insmed Reports First Quarter 2020 Financial Results and Provides Business Update 8.0%
10/11 Insmed Incorporated (NASDAQ: INSM) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 7.9%
4/2 Insmed Appoints Carol A. Schafer to its Board of Directors 7.1%
10/30 Form 10-Q INSMED Inc For: Sep 30 6.7%
4/20 Insmed to Host First Quarter 2020 Financial Results Conference Call on Thursday, April 30, 2020 6.5%
1/7 Form 4 INSMED Inc For: Jan 03 Filed by: SORIANO JOHN 6.1%
6/12 Form 3 INSMED Inc For: Jun 03 Filed by: GOLL JOHN 5.7%
Top News Decliners
2/25 Q4/2019 12/31/2019 EPS -0.590 ZacksConsensus -0.590 ActVsEst 0.000 - In-Line -16.4%
5/7 Q1/2019 3/31/2019 EPS -0.960 ZacksConsensus -0.940 ActVsEst (0.020) - Miss -13.0%
8/1 Q2/2019 6/30/2019 EPS -0.810 ZacksConsensus -0.850 ActVsEst 0.040 - Beat -12.3%
2/26 Galapagos Ratings Downgrade, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha] -8.1%
3/31 Form DEFA14A INSMED Inc -6.6%
8/2 Insmed, Inc. (INSM) CEO Will Lewis on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -6.1%
5/20 New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease -5.9%
3/7 Insmed Incorporated (NASDAQ: INSM) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -5.9%
3/5 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) -5.7%
1/16 Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at JMP Securities. They now have a $40.00 price target on the stock. -5.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3